Although coffee and green tea are suggested to reduce the risk of some types of cancers, only a few epidemiological studies have investigated their effect on the risk of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Here, we investigated the association of coffee and green tea consumption and the risk of AML and MDS in a large-scale population-based cohort study in Japan. A total of 95,807 Japanese subjects (45,937 men and 49,870 women; age 40-69 years at baseline) were followed to the end of 2012, for an average of 18 years. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) for the association between coffee and green tea consumption at baseline and the risk of AML and MDS were assessed using a Cox proportional hazards model with adjustment for potential confounders. During 1,751.956 person-years, we identified 85 AML cases and 70 MDS cases. Our findings showed no significant association between coffee consumption and the risk of AML, or between green tea consumption and the risk of AML or MDS. In contrast, we observed a decreasing dose-response relationship between coffee consumption and the risk of MDS among men (almost none: reference, 1-4 times/week: HR 5 0.83, 95% CI: 0.43-1.62; 1cups/day: HR 5 0.47, 0.22-0.99, p for trend 5 0.049). Stratified analysis by smoking status suggested that the observed relative risk for AML and MDS of coffee drinkers relative to non-coffee drinkers might be due to residual confounding by smoking. These findings deserve further investigation in future studies.
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represent a genetically heterogeneous group of myeloid neoplasms which primarily affect older adults.
1,2 Because they have high morbidity and mortality, a precise understanding of the etiology of both diseases is important for prevention, but this is poorly understood at present, particularly among Asian populations. In addition, the possibility of differences in the incidence and characteristics of hematological malignancies between Asian and Western populations warrants investigation in Asian populations. [3] [4] [5] Coffee and green tea are both widely consumed beverages around the world. Coffee contains complex mixtures of biochemically active compounds that may have genotoxic and mutagenic properties. 6 Green tea also contains a variety of compounds that are beneficial for health, including caffeine and polyphenol catechins. 7 Epidemiological studies suggest that coffee and green tea reduce the risk of some types of cancers. 8, 9 However, few studies have investigated their effect on the risk of AML and MDS, and their results were inconsistent.
Here, we investigated the association between coffee and green tea consumption and the subsequent risk of AML and MDS in a large-scale population-based cohort study in Japan.
Material and Methods

Study population
The study design, study population, questionnaire, and followup information of the Japan Public Health Center-based Prospective Study have been detailed in previous articles. [10] [11] [12] Tokyo) and Cohort II covered six areas (Ibaraki, Niigata, Kochi, Nagasaki, Okinawa and Osaka). 11 A baseline self-administered questionnaire survey on various lifestyle factors, including coffee and green tea consumption, was conducted in 1990 for Cohort I and in 1993 to 1994 for Cohort II, with a high response rate (81%). 12 In the present analysis, we excluded subjects who met any of the following exclusion criteria: (i) unavailability of incidence data (Tokyo area and Suita area in Osaka) (ii) non-Japanese nationality; (iii) late report of emigration before the start of the follow-up period; (iv) incorrect birth date; (v) duplicate registration; (vi) later withdrawal of consent; (vii) self-reported history of cancer at baseline survey; or (viii) missing values for coffee or green tea consumption. Finally, we included a total of 95,807 subjects (45,937 men and 49,870 women) in this analysis. The study protocol was approved by the institutional review boards of the National Cancer Center, Japan, and Aichi Cancer Center Research Institute.
Outcomes
Study outcomes were defined as the incidence of newly occurring AML and MDS diagnosed during the study period. The occurrence of AML and MDS was identified using active patient notification from major local hospitals in the study area and data collection from population-based cancer registries, with approval. We used death certificate files, with permission, as a supplement. The proportion of cases where incidence was ascertained using a death certificate only was 16.5% for AML and 7.1% for MDS. AML and MDS were coded using the International Classification of Diseases for Oncology, Third Edition (ICD-O-3). 13 We defined the ICD- 
Exposure data
Exposure data were retrieved from a baseline self-administered questionnaire survey about various health habits, including coffee and green tea consumption. Information on coffee and green tea consumption was obtained in terms of the frequency and amount of each beverage consumed according to the following categories: hardly ever, 1-2 days/week, 3-4 days/week and almost daily (further divided into 1-2 cups/day, 3-4 cups/ day or 5 cups/day). For the present analysis, we further classified these categories based on their distribution among the subjects as follows: coffee consumption (almost none, 1-4 times/week, 1 cup/day) and green tea consumption (<1 cup/ day, 1-2 cups/day, 3-4 cups/day, 5cups/day).
Statistical analysis
Person-years of follow-up for incidence of AML and MDS were accrued from the date of the baseline survey until the date of occurrence of AML or MDS, emigration from the study area, death, or end of the study period, whichever came first. Subjects lost to follow-up were censored at the last confirmed date of presence in the study area. Differences in characteristics between categories of coffee and green tea consumption were evaluated by analysis of variance and v 2 test. The hazard ratios (HRs) and 95% confidence intervals (CIs) of AML and MDS were calculated in the categories for coffee consumption (almost none, 1-4 times/week, 1 cups/ day) and green tea consumption (<1 cup/day, 1-2 cups/day, 3-4 cups/day, 5cups/day), with the lowest consumption category as the reference. We estimated two types of HR: Model 1, which adjusted for age at baseline (continuous), gender (men or women) and study area (10 PHC areas); and Model 2, which adjusted for age at baseline, gender, smoking status (never, former and current [<30, 30 pack-years]), alcohol category (non-drinkers, occasional drinkers, <300 ethanol intake/week and for 300 ethanol intake/week), body mass index (<18.5, 18.5-24.9, 25-29.9 and 30 kg/m 2 ), occupation (professional or office worker, sales clerk or other, farmer, manual laborer, unemployed and missing) and study area (10 PHC areas). Furthermore, we calculated the HRs of AML and MDS for coffee and green tea consumption stratified by smoking status (never, ever). For stratified analyses by smoking status, we also estimated another type of HR: Model 3. This adjusted for age at baseline, gender, alcohol category, body mass index, occupation, study area (10 PHC areas) and What's new? Although coffee and green tea are suggested to reduce the risk of some types of cancers, only a few epidemiological studies have investigated their effect on the risk of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). This population-based cohort study in Japan showed that coffee consumption was inversely associated with the risk of MDS among men. No significant association was observed between coffee and the risk of AML, or between green tea and the risk of AML/MDS. The observed relative risk for AML/MDS of coffee drinkers relative to non-coffee drinkers might be due to residual confounding by smoking.
Cancer Epidemiology Table 1 . Baseline characteristics of study subjects by coffee and green tea consumption Baseline characteristics of study subjects according to coffee and green tea consumption are shown in Table 1 . Participants with higher coffee consumption tended to be younger and were more likely to smoke cigarettes among both men and women. On the other hand, participants with higher green tea consumption tended to be older. Former and current smokers were more prevalent among men than women. Similarly, heavy drinkers (300 ethanol g/week) were more prevalent among men than women. Table 2 shows the adjusted HRs for AML in relation to coffee and green tea consumption. Overall, there was no statistically significant association of coffee or green tea consumption with the risk of AML. Table 3 shows the adjusted HRs for MDS in relation to coffee and green tea consumption. When we adjusted for age, gender, smoking status, alcohol category, body mass index, occupation and study area (Model 2), we observed a decreasing dose-response relationship between coffee consumption and the risk of MDS among men (almost none: reference, 1-4 times/week: HR 5 0.83, 0.43-1.62; 1 cups/ day: HR 5 0.47, 0.22-0.99, p for trend 5 0.049). This association was not observed among women, but the number of the female MDS cases was small. In addition, we did not observe a significant association between green tea consumption and the risk of MDS.
We also evaluated the association of coffee and green tea with the risk of AML and MDS by smoking status. Compared with those who hardly drank coffee, coffee drinkers who drank 1 or more cups per week had a reduced risk of AML and MDS among never smoking men, although the results were not statistically significant (Supporting Information Tables S1 and S2).
Because both AML and MDS can occur in cancer survivors as a result of the treatment for the first cancer, we also performed an analysis including subjects who self-reported a history of cancer, but none of the results were substantially altered (Supporting Information Tables S3 and S4 ).
Discussion
In this prospective cohort study, we found that coffee consumption was inversely associated with the risk of MDS among Japanese men. This inverse association was not observed among women. In contrast, we did not find any Table 1 . Baseline characteristics of study subjects by coffee and green tea consumption (Continued) 
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significant association between coffee consumption and the risk of AML or between green tea consumption and the risk of AML or MDS. Because smoking is an established risk factor for AML and MDS 11, [15] [16] [17] [18] and our participants with higher coffee consumption were more likely to smoke, detailed adjustment for smoking as a confounder was important. Stratified analysis by smoking status suggested a possible protective effect of coffee for AML among never smoking men, although the results were not statistically significant (Supporting Information Table S1 ). In addition, among ever smoking men, further adjustment for pack-years attenuated the HRs for AML of coffee drinkers relative to non-coffee drinkers in Model 3. This suggested that the observed relative risk for AML among ever smokers might be affected by residual confounding by smoking. Although we observed a protective association of coffee only with the risk of MDS, and not with the risk of AML among men, a possible protective effect of coffee on the risk of AML should be assessed by future studies which include detailed consideration of smoking. In addition, the heterogeneous results in previous studies might be explained by residual confounding by smoking. Care should therefore be taken in analyzing the results of previous studies, especially the results of analyses which did not adjust for smoking.
We observed a significant protective association of coffee on the risk of MDS among men. Conversely, coffee tended to increase the risk of MDS among women although the number of female MDS cases was small. One explanation for this discrepancy is that men and women differ in their responses to coffee and that these differences may be mediated by changes in circulating sex-related hormones. 19, 20 A second possibility is that the results were affected by the differences in baseline characteristics between men and women, albeit that we tried to adjust for potential confounders. While coffee consumption was positively associated with smoking among both men and women, the prevalence of smokers was considerably higher among men than women (Table 1) , suggesting residual confounding by smoking might have affected the observed results in men more than women. The results of this study, therefore, should be interpreted with caution.
Only a few studies have examined the effect of coffee and green tea consumption on the risk of MDS. Pekmezovic et al. reported a significant positive association between coffee consumption and the risk of MDS in a case-control study of 80 MDS cases and 160 controls in Serbia Montenegro, with an odds ratio (OR) of 4.8 (95% CI, 2.2-10.8) for coffee drinkers relative to non-drinkers. 21 Another case-control study in western Greece of 126 MDS cases and 102 controls did not observe a significant association. 22 However, these results might have been affected by potential confounders, including smoking, for which they were not adjusted. With regard to green tea, only one case-control study in China (208 cases and 208 controls) has evaluated the effect, and this reported a significant dose-dependent protective effect of tea consumption (mainly green tea) with the risk of MDS after adjustment for potential confounders (nondrinkers: reference, 1 cup/day: HR 5 0.25, 0.11-0.61; 2 cup/day: HR 5 0.44, 0.22-0.89, p for trend 5 0.02). 23 The inconsistency of this study and our present finding might be due to the former's retrospective design. Confirmation of our results will require further prospective studies which adjust for potential confounders.
Any of several mechanistic pathways may explain the protective effect of coffee on the development of MDS. Coffee contains more than thousand different chemicals with potential biological activity, including phenolic compounds (such as chlorogenic and caffeic acids) and cafestol and kahweol with anticarcinogenic activity. 6, 24, 25 Phenolic compounds found in coffee have shown strong antioxidant properties and anti-carcinogenic effects under certain conditions. 6, 8 In animal models, cafestol and kahweol were shown to reduce the genotoxicity and DNA damage from several carcinogens. 24 In addition, a protective effect of coffee consumption on the risk of developing malignancy might also be related to the inhibition of oxidative stress, regulation of DNA repair, apoptosis and inflammation. 8 Recent studies suggested that escape of immune surveillance by innate and adaptive immune system may be crucial for the development of MDS. 26, 27 Enhanced immune surveillance by coffee might contribute to the protective effect on the risk of MDS. Furthermore, green tea did not show a protective effect against MDS in the present analysis. This may suggest that the protective effect for MDS was not necessarily due to caffeine because both coffee and green tea have caffeine. Additional experimental studies are required to clarify the mechanism of the effect of coffee on the risk of MDS.
Previous studies of the association between coffee and green tea consumption and the risk of AML have been inconsistent. For coffee, a case-control study of 111 AML cases and 439 controls in the USA observed a marginal association between higher coffee intake and an increased risk of AML only among women (OR for the highest versus lowest category 5 2.08, 95% CI 0.98-4.39). 28 In contrast, a population-based case-control study in Northern Italy of 294 leukemia cases (including 95 myeloid) and 279 controls did not observe an association between coffee consumption and the risk of myeloid malignancy, including AML and MDS. 29 Another multicentre case-control study of 651 leukemia cases (including 223 AML) and 1,771 controls in Italy also failed to find a significant association. 30 Only one prospective cohort study has appeared to date; this involved 471,799 participants and 338 AML cases, and suggested that coffee reduced the risk of AML (non-drinkers: reference, < 500 g/ day: HR 5 0.67, 0.47-0.96; 500 and <1,000 g/day: HR 5 0.62, 0.44-0.88; 1,000 g/day: HR 5 0.62, 0.44-0.88, p for trend 5 0.24). 31 Although the analyses of that study adjusted for potential confounders, including smoking, the authors could not exclude the possibility of the effect of residual confounding. These inconsistent results for the association of coffee and the risk of AML warrant further evaluation across multiple populations.
With regard to the effect of green tea, a case-control study of 442 leukemia cases (including 67% AML cases) and 279 controls in China reported a significant protective effect of green tea on the risk of leukemia (non-drinkers: reference, < 1 cup/day: HR 5 1.30, 0.77-2.19; 1 cup/day: HR 5 0.74, 0.37-1.45; 2 cups/day: HR 5 0.31, 0.44-0.88, p for trend < 0.01). 32 In contrast, the protective effect of green tea on the risk of AML was not observed in another case-control study of 107 leukemia cases (including 72 AML) and 110 controls in China. 33 The Ohsaki Study, a population-based cohort study in Japan which involved 41,761 participants and 36 cases of myeloid malignancy, also failed to find a significant association between green tea consumption and the risk of myeloid malignancy, including AML and MDS. 34 Consistent with these studies, our results do not support an association between green tea consumption and the risk of AML.
This study has several strengths. The major strength is its prospective design, in which information was collected before the subsequent diagnosis of AML/MDS. This avoided the exposure recall bias inherent to case-control studies. Further, subjects were selected from the general population, and the response rate to the questionnaire (>80%) was acceptable for this study setting while the loss to follow-up (0.8%) was negligible. The limitations of analyses derived from the JPHC study have been described in previous articles. 11, 35, 36 Here, we mention only important limitations specifically inherent to this study. First, we could not evaluate the risk of AML and MDS by subtype because most cases were categorized as having an unspecified subtype. Second, since MDS did not become reportable to the Japanese cancer registry until 2002, some MDS cases might not have been reported, although a sensitivity analysis excluding observations prior to 2002 did not change the results substantially (Supporting Information  Table S5 ). Third, the diagnostic criteria of MDS changed from the French-American-British classification to the World Health Organization classification during the follow-up period. This transition of definition of MDS may have affected the number of the reported cases. Forth, information on coffee and green consumption was evaluated solely on the basis of a single selfreport, and misclassification of exposure due to changes in coffee and green consumption before study enrollment and during the study period might have occurred. Finally, we cannot completely rule out the effects of residual confounding by measured and unmeasured potential confounders.
In conclusion, we observed an inverse association between coffee consumption and the risk of MDS among Japanese men. In contrast, our results do not support an association between coffee or green tea consumption and the risk of AML, or an association between green tea consumption and the risk of MDS. This study also suggested that the observed relative risk for AML and MDS of coffee drinkers relative to non-coffee drinkers might be due to residual confounding by smoking. These findings deserve further investigation in future studies.
